Literature DB >> 7092291

Bone mineral homeostasis, bone growth, and mineralisation during years of pubertal growth: a unifying concept.

S Krabbe, I Transbøl, C Christiansen.   

Abstract

Serum calcium, magnesium proteins, phosphate, and immunoparathyroid hormone were measured in 338 normal children and adolescents aged between 7 and 20 years and in 123 normal adults aged between 21 and 50 years. Protein corrected serum calcium and magnesium remained stable throughout the study. Despite hyperphosphataemia protein corrected calcium exceeded the concentrations of normal adults. Serum phosphate and the Ca X P product greatly exceeded adult values and fell rather slowly towards adult levels after the pubertal growth spurt. Serum immunoparathyroid hormone tended to exceed normal adult values and was judged high for the level of serum calcium. Similarities between mineral metabolism in childhood an adolescence and in acromegaly were striking. On this basis in the light of studies demonstrating stimulatory actions of gonadal hormones on growth hormone and of growth hormone on the secretion of parathyroid hormone and 1,25-dihydroxyvitamin D3, a unifying concept is developed. This concept places growth hormone in the unique position of being the main driver and co-ordinator during childhood and adolescence of bone growth an mineralisation on the one hand, and of blood mineral homeostasis on the other. Gonadal hormones probably express some of their actions through stimulation of growth hormone secretion and others by different mechanisms. According to this concept growth hormone is maintaining th Ca X P product at a suitable high level as long as growth hormone and gonadal hormones deliver bone matrix for mineralisation at a high rate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092291      PMCID: PMC1627552          DOI: 10.1136/adc.57.5.359

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  30 in total

1.  Relation between bone mass and muscle weight.

Authors:  F Doyle; J Brown; C Lachance
Journal:  Lancet       Date:  1970-02-21       Impact factor: 79.321

2.  Plasma calcium, magnesium, phosphorus, and alkaline phosphatase levels in normal British schoolchildren.

Authors:  J M Round
Journal:  Br Med J       Date:  1973-07-21

3.  Cortical bone mass in acromegaly.

Authors:  D G Ikkos; K Ntalles; C Velentzas; P Katsichtis
Journal:  Acta Radiol Diagn (Stockh)       Date:  1974-03

4.  Serum parathyroid hormone and blood minerals: interrelationships in normal children.

Authors:  S B Arnaud; R S Goldsmith; G B Stickler; J T McCall; C D Arnaud
Journal:  Pediatr Res       Date:  1973-05       Impact factor: 3.756

5.  Calcium absorption and excretion in the gut in acromegaly.

Authors:  G Sigurdsson; V Nunziata; M Reiner; A Nadarajah; G F Joplin
Journal:  Clin Endocrinol (Oxf)       Date:  1973-07       Impact factor: 3.478

6.  Growth and renal control of plasma phosphate.

Authors:  J Corvilain; M Abramow
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

7.  Integrated concentrations of growth hormone correlated with plasma testosterone and bone age in preadolescent and adolescent males.

Authors:  R G Thompsom; A Rodriguez; A Kowarski; C J Migeon; R M Blizzard
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

8.  The nature of the metabolic bone disorder in acromegaly.

Authors:  B L Riggs; R V Randall; H W Wahner; J Jowsey; P J Kelly; M Singh
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

9.  The role of phosphate in the secretion of parathyroid hormone in man.

Authors:  E Reiss; J M Canterbury; M A Bercovitz; E L Kaplan
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

10.  Serum concentrations of parathyroid hormone in infants, children, and adolescents.

Authors:  A Root; A Gruskin; R M Reber; A Stopa; G Duckett
Journal:  J Pediatr       Date:  1974-09       Impact factor: 4.406

View more
  15 in total

Review 1.  Peak bone mass.

Authors:  J P Bonjour; G Theintz; F Law; D Slosman; R Rizzoli
Journal:  Osteoporos Int       Date:  1994       Impact factor: 4.507

2.  An inflection point of serum 25-hydroxyvitamin D for maximal suppression of parathyroid hormone is not evident from multi-site pooled data in children and adolescents.

Authors:  Kathleen M Hill; George P McCabe; Linda D McCabe; Catherine M Gordon; Steven A Abrams; Connie M Weaver
Journal:  J Nutr       Date:  2010-09-22       Impact factor: 4.798

Review 3.  Vitamin D in childhood and adolescence.

Authors:  Kevin D Cashman
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

4.  Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults.

Authors:  Kerry S Jones; Inez Schoenmakers; Les J C Bluck; Shujing Ding; Ann Prentice
Journal:  Br J Nutr       Date:  2011-09-07       Impact factor: 3.718

5.  Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty.

Authors:  G Saggese; S Bertelloni; G I Baroncelli; R Battini; G Franchi
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

6.  Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone.

Authors:  Stefano Picca; Marco Cappa; Chiara Martinez; Seyoum Ido Moges; John Osborn; Francesco Perfumo; Gianluigi Ardissino; Roberto Bonaudo; Giovanni Montini; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

7.  Vitamin D status and parathyroid hormone relationship in adolescents and its association with bone health parameters: analysis of the Northern Ireland Young Heart's Project.

Authors:  T R Hill; A A Cotter; S Mitchell; C A Boreham; W Dubitzky; L Murray; J J Strain; A Flynn; P J Robson; J M W Wallace; M Kiely; K D Cashman
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

8.  Association between vitamin D status and serum parathyroid hormone concentration and calcaneal stiffness in Japanese adolescents: sex differences in susceptibility to vitamin D deficiency.

Authors:  Naoko Tsugawa; Kazuhiro Uenishi; Hiromi Ishida; Reo Ozaki; Tomoki Takase; Takuya Minekami; Yuri Uchino; Maya Kamao; Toshio Okano
Journal:  J Bone Miner Metab       Date:  2015-08-12       Impact factor: 2.626

9.  Growth hormone secretion in poorly growing children with renal hypophosphataemic rickets.

Authors:  G Saggese; G I Baroncelli; S Bertelloni; G Perri
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

10.  Bone loss during gonadotropin-releasing hormone agonist treatment in girls with true precocious puberty is not due to an impairment of calcitonin secretion.

Authors:  G Saggese; S Bertelloni; G I Baroncelli; D Pardi; L Cinquanta
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.